Continuous Monitoring Of Left Ventricular Function Research Articles

Continuous monitoring of left ventricular function in postoperative intensive care patients using artificial intelligence and transesophageal echocardiography

BackgroundContinuous monitoring of mitral annular plane systolic excursion (MAPSE) using transesophageal echocardiography (TEE) may improve the evaluation of left ventricular (LV) function in postoperative intensive care patients. We aimed to assess the utility of continuous monitoring of LV function using TEE and artificial intelligence (autoMAPSE) in postoperative intensive care patients.MethodsIn this prospective observational study, we monitored 50 postoperative intensive care patients for 120 min immediately after cardiac surgery. We recorded a set of two-chamber and four-chamber TEE images every five minutes. We defined monitoring feasibility as how often the same wall from the same patient could be reassessed, and categorized monitoring feasibility as excellent if the same LV wall could be reassessed in ≥ 90% of the total recordings. To compare autoMAPSE with manual measurements, we rapidly recorded three sets of repeated images to assess precision (least significant change), bias, and limits of agreement (LOA). To assess the ability to identify changes (trending ability), we compared changes in autoMAPSE with the changes in manual measurements in images obtained during the initiation of cardiopulmonary bypass as well as before and after surgery.ResultsMonitoring feasibility was excellent in most patients (88%). Compared with manual measurements, autoMAPSE was more precise (least significant change 2.2 vs 3.1 mm, P < 0.001), had low bias (0.4 mm), and acceptable agreement (LOA − 2.7 to 3.5 mm). AutoMAPSE had excellent trending ability, as its measurements changed in the same direction as manual measurements (concordance rate 96%).ConclusionContinuous monitoring of LV function was feasible using autoMAPSE. Compared with manual measurements, autoMAPSE had excellent trending ability, low bias, acceptable agreement, and was more precise.Graphical

Left ventricular function can be continuously monitored with an epicardially attached accelerometer sensor

Preservation of left ventricular (LV) function is crucial for a beneficial outcome in high-risk patients undergoing cardiac surgery. The present study evaluated a motion sensor (accelerometer) for continuous monitoring of LV performance during changes in global and regional LV function. In 11 pigs, an accelerometer was sutured to the epicardium on the anterior apical LV region. Global LV function was modulated by esmolol, epinephrine and fluid loading, whereas regional LV dysfunction was induced by a 3-min occlusion of left anterior descending (LAD) coronary artery. Epicardial acceleration in the circumferential direction was obtained by the accelerometer, and from this signal, epicardial velocity was calculated. Peak systolic velocity was measured and used as an index of LV performance. The accelerometer was compared with left ventricular stroke work (LVSW), ejection fraction and myocardial strain by echocardiography. Accelerometer peak systolic velocity and LVSW changed significantly during all interventions, affecting global LV function. Systolic velocity by the accelerometer increased during epinephrine and fluid loading from 14.1 [10.2; 17.3] to 25.4 [16.7; 28.5] (P < 0.05) and 14.8 [12.5; 18.5] cm/s (P < 0.05), respectively. Esmolol infusion significantly decreased accelerometer peak systolic velocity to 9.4 [7.3; 10.7] cm/s (P < 0.05). Minor changes were seen in the echocardiographic measurements, with significant changes only observed in myocardial strain during the interventions with esmolol and epinephrine. Regional LV dysfunction was clearly detected by the accelerometer during LAD occlusion, and peak systolic velocity was reduced from 14.1 [10.2; 17.3] to 5.7 [5.0; 6.8] cm/s (P < 0.05). The accelerometer demonstrated higher sensitivity and specificity for the detection of myocardial ischaemia than LVSW and ejection fraction. For all interventions, accelerometer peak systolic velocity correlated strongly with LVSW (r = 0.81, P < 0.01) and myocardial strain (r = 0.80; P < 0.01). It was possible to obtain accurate information on LV performance by the use of an epicardially attached accelerometer. The method allows continuous monitoring of LV function and may therefore improve perioperative monitoring of cardiac surgery patients.

Left ventricular function changes during pharmacological and physiological interventions and routine activities monitored in healthy volunteers by a portable radionuclide probe (VEST)

A miniaturized radionuclide cardiac probe incorporated in a semi-rigid plastic chest garment has made ambulatory left ventricular (LV) function evaluation possible, with gated nuclear data being stored on tape together with electrocardiographic data, for subsequent off-line processing. After red blood cell labelling with 555 MBq (15 mCi) 99mTc and standard gated blood pool imaging in 45 degrees LAO, we performed a continuous monitoring of LV function in 20 healthy male volunteers (age range: 22-25 years), in resting control conditions as well as during activities (standing, walking, climbing stairs) and after interventions (isosorbide dinitrate intake, Trendelenburg position, inflation of cuffs around the thighs). VEST-monitoring proved to be a reliable method that gave reproducible results: changes of ejection (EF) in basal conditions were lower than 5% in 95% of the patients. Changes in LV function caused by daily activities were easily demonstrated. While standing effected no significant EF changes, walking and climbing increased EF by 6.9% (p less than 0.05) and 21.2% (p less than 0.05) respectively. Changes in LV volumes caused by alterations in venous return were also demonstrated. Compared with baseline, Trendelenburg increased end-diastolic volume (EDV) by 2.9% while isosorbide dinitrate and inflation of cuffs decreased it by 5.7% and 2.2% respectively.

Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery

Silent myocardial ischemia has been inferred from transient ST-segment depression during continuous electrocardiographic monitoring. Recently, continuous ambulatory monitoring of left ventricular (LV) function using a radionuclide technique (VEST) has demonstrated episodes of significant silent LV dysfunction in the absence of electrocardiographic changes. To validate the demonstration of silent LV dysfunction with this technique, 12 men were studied during percutaneous transluminal coronary angioplasty. A total of 18 left anterior descending coronary artery balloon inflations were performed. Balloon inflations at 8 ± 2 atm (4 to 10 atm) lasted 70 ± 16 seconds. Seventeen of 18 inflations were associated with a decrease in LV ejection fraction >0.10. Mean LV ejection fraction decreased from 0.53 ± 0.08 to 0.28 ± 0.11 (p < 0.0001). In contrast, there was pain in only 10 inflations and ST-segment changes in 7. LV dysfunction was associated with a minimal increase in enddiastolic volume (4 ± 3%, p < 0.003), and a major increase in relative end-systolic volume (69 ± 43%, p < 0.001). These data suggest that continuous monitoring of LV function with the VEST can sensitively detect silent ischemic decreases in LV function occurring during angioplasty, and provide further validation of the use of this technique for detecting silent myocardial ischemia.